Lifestyle

Roche has so impressed since ASCO with its various drug results - including its "smart bomb" breast cancer drug trastuzumab emtansine (T-DMI) - that the company's stock (RHHBY) shot up on the OTC Markets.

Counterfeit medicines are not just a theoretical problem anymore. Now is the time to close a major loophole that allows the purveyors of false products to prey on an unsuspecting American public.